Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

  • Price (USD)0.854
  • Today's Change0.0015 / 0.18%
  • Shares traded229.65k
  • 1 Year change-4.04%
  • Beta0.2622
Data delayed at least 20 minutes, as of Jul 04 2024 16:35 BST.
More ▼
Total returns on $1000
1Y
Fund/benchmarkChange
PriceBioPharma Credit PLC (Ordinary Share)+8.33%
NAVBioPharma Credit PLC (Ordinary Share)+10.69%
Morningstar's BenchmarkNo benchmark--

Key statistics

On Thursday, BioPharma Credit PLC (BPCR:LSE) closed at 0.854, 5.43% above its 52-week low of 0.81, set on Nov 09, 2023.
52-week range
Today
0.81Nov 09 20230.944Jan 30 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding1.22bn
Market cap1.04bn USD
Total assets1.23bn USD
Total expense ratio1.15%
High0.868
Low0.854
Previous close0.8525
Average volume2.70m
YTD Change+1.67%
Beta0.2622
Diluted NAV (est)1.01
Diluted NAV (last pub)1.00
Premium/Discount-13.56%
Net Gearing0.00%
Annual div (ADY)0.070 USD
Annual div yield (ADY)8.05%
Div ex-dateJul 04 2024
Div pay-dateJul 31 2024
Data delayed at least 20 minutes, as of Jul 04 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.